stopwords, and 2-character and smaller words are excluded
TICAM-1, an adaptor molecule that participates in Toll-like
receptor 3-mediated interferon-beta induction
Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T
NATURE IMMUNOLOGY 4 (2): 161-167 FEB 2003
and the citing papers
Total: 668, Nodes: 194, Word count: 1792, All words count: 2511
View: Overview. Sorted by word.
Page 1 of 4: [ 1 2 3 4 ]
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 1 | A46R | 1 | 0.5 | 0 | 1
|
| 2 | ABSENCE | 1 | 0.5 | 0 | 3
|
| 3 | ACID | 2 | 1.0 | 1 | 9
|
| 4 | ACID-MEDIATED | 1 | 0.5 | 0 | 3
|
| 5 | ACIDS | 2 | 1.0 | 3 | 17
|
| 6 | ACQUIRED | 1 | 0.5 | 0 | 1
|
| 7 | ACTION | 1 | 0.5 | 0 | 0
|
| 8 | ACTIVATE | 1 | 0.5 | 1 | 3
|
| 9 | ACTIVATED | 1 | 0.5 | 2 | 12
|
| 10 | ACTIVATES | 3 | 1.5 | 32 | 63
|
| 11 | ACTIVATION | 26 | 13.4 | 76 | 311
|
| 12 | ACTIVITIES | 1 | 0.5 | 0 | 10
|
| 13 | ACTIVITY | 1 | 0.5 | 0 | 0
|
| 14 | ACUTE | 1 | 0.5 | 0 | 12
|
| 15 | ADAPTER | 8 | 4.1 | 60 | 90
|
| 16 | ADAPTERS | 2 | 1.0 | 56 | 105
|
| 17 | ADAPTIVE | 7 | 3.6 | 2 | 12
|
| 18 | ADAPTOR | 12 | 6.2 | 331 | 511
|
| 19 | ADAPTOR-INDUCING | 1 | 0.5 | 2 | 4
|
| 20 | ADAPTORS | 4 | 2.1 | 9 | 50
|
| 21 | ADJUVANCY | 1 | 0.5 | 0 | 1
|
| 22 | ADJUVANT | 1 | 0.5 | 2 | 12
|
| 23 | ADJUVANT-MEDIATED | 1 | 0.5 | 2 | 2
|
| 24 | AFFERENT | 1 | 0.5 | 1 | 3
|
| 25 | AGONIST | 2 | 1.0 | 4 | 18
|
| 26 | AGONISTS | 2 | 1.0 | 3 | 23
|
| 27 | AIRWAY | 1 | 0.5 | 0 | 1
|
| 28 | AKT | 1 | 0.5 | 3 | 17
|
| 29 | ALLERGIC | 1 | 0.5 | 0 | 0
|
| 30 | ALLOGRAFTS | 1 | 0.5 | 0 | 3
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 31 | ALLOIMMUNITY | 1 | 0.5 | 0 | 1
|
| 32 | ALLOWS | 2 | 1.0 | 0 | 10
|
| 33 | ALTERNATE | 1 | 0.5 | 0 | 0
|
| 34 | ALTERNATIVE | 1 | 0.5 | 0 | 0
|
| 35 | ANALYSIS | 2 | 1.0 | 3 | 19
|
| 36 | ANIMAL | 1 | 0.5 | 0 | 0
|
| 37 | ANTAGONISTS | 1 | 0.5 | 0 | 4
|
| 38 | ANTI-INFLAMMATORY | 1 | 0.5 | 0 | 1
|
| 39 | ANTICIPATED | 1 | 0.5 | 0 | 0
|
| 40 | ANTIFUNGAL | 1 | 0.5 | 0 | 0
|
| 41 | ANTIVIRAL | 9 | 4.6 | 24 | 100
|
| 42 | AP-1-DEPENDENT | 1 | 0.5 | 5 | 9
|
| 43 | APC-INDEPENDENT | 1 | 0.5 | 4 | 15
|
| 44 | APOPTOSIS | 4 | 2.1 | 3 | 11
|
| 45 | APOPTOTIC | 1 | 0.5 | 1 | 2
|
| 46 | APPROACH | 1 | 0.5 | 0 | 9
|
| 47 | APPROACHES | 1 | 0.5 | 0 | 0
|
| 48 | APPROPRIATION | 1 | 0.5 | 1 | 2
|
| 49 | ARTHRITIS | 1 | 0.5 | 1 | 15
|
| 50 | ARTHRITOGENIC | 1 | 0.5 | 0 | 1
|
| 51 | ASSAY | 1 | 0.5 | 0 | 10
|
| 52 | ASSESSMENT | 1 | 0.5 | 0 | 10
|
| 53 | ASSOCIATED | 1 | 0.5 | 0 | 0
|
| 54 | ASSOCIATES | 1 | 0.5 | 31 | 53
|
| 55 | ASSOCIATION | 1 | 0.5 | 0 | 8
|
| 56 | ASTROCYTES | 2 | 1.0 | 1 | 1
|
| 57 | ATTRACTION | 1 | 0.5 | 0 | 0
|
| 58 | AUTOIMMUNE | 1 | 0.5 | 0 | 0
|
| 59 | AUTOPHOSPHORYLATION | 1 | 0.5 | 0 | 6
|
| 60 | AUTOREGULATORY | 1 | 0.5 | 0 | 0
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 61 | AVAILABILITY | 1 | 0.5 | 0 | 6
|
| 62 | B-ACTIVATING | 1 | 0.5 | 0 | 1
|
| 63 | B-AND | 1 | 0.5 | 5 | 9
|
| 64 | BACILLUS | 1 | 0.5 | 8 | 14
|
| 65 | BACTERIA | 1 | 0.5 | 1 | 2
|
| 66 | BACTERIA-INFECTED | 1 | 0.5 | 0 | 5
|
| 67 | BACTERIAL | 5 | 2.6 | 11 | 95
|
| 68 | BASED | 1 | 0.5 | 0 | 2
|
| 69 | BCG | 3 | 1.5 | 2 | 8
|
| 70 | BETA | 2 | 1.0 | 4 | 16
|
| 71 | BETA-STAT | 1 | 0.5 | 0 | 4
|
| 72 | BIOINFORMATICS | 1 | 0.5 | 0 | 0
|
| 73 | BIOLOGICAL | 1 | 0.5 | 7 | 23
|
| 74 | BIOLOGY | 1 | 0.5 | 0 | 3
|
| 75 | BLOCK | 1 | 0.5 | 1 | 24
|
| 76 | BLOCKING | 1 | 0.5 | 8 | 14
|
| 77 | BOVINE | 1 | 0.5 | 1 | 24
|
| 78 | BOVIS | 3 | 1.5 | 10 | 21
|
| 79 | BRIDGE | 1 | 0.5 | 1 | 6
|
| 80 | BRIDGING | 1 | 0.5 | 38 | 51
|
| 81 | BRUTON | 1 | 0.5 | 0 | 4
|
| 82 | BTK | 1 | 0.5 | 0 | 4
|
| 83 | C-JUN | 1 | 0.5 | 1 | 1
|
| 84 | CAENORHABDITIS | 2 | 1.0 | 5 | 27
|
| 85 | CALMETTE-GUERIN | 1 | 0.5 | 8 | 14
|
| 86 | CANCER | 1 | 0.5 | 2 | 12
|
| 87 | CARDIAC | 1 | 0.5 | 0 | 4
|
| 88 | CASCADES | 1 | 0.5 | 1 | 3
|
| 89 | CATIONIC | 1 | 0.5 | 0 | 0
|
| 90 | CD11C | 1 | 0.5 | 0 | 3
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 91 | CDNA | 1 | 0.5 | 2 | 5
|
| 92 | CELL | 12 | 6.2 | 16 | 101
|
| 93 | CELL-DERIVED | 1 | 0.5 | 0 | 3
|
| 94 | CELL-WALL | 1 | 0.5 | 0 | 1
|
| 95 | CELLS | 20 | 10.3 | 50 | 239
|
| 96 | CELLULAR | 1 | 0.5 | 0 | 0
|
| 97 | CENTER | 1 | 0.5 | 19 | 43
|
| 98 | CENTRAL | 2 | 1.0 | 16 | 46
|
| 99 | CHARACTERIZATION | 2 | 1.0 | 0 | 4
|
| 100 | CHEMOKINE | 1 | 0.5 | 0 | 0
|
| 101 | CHEMOKINES | 1 | 0.5 | 1 | 1
|
| 102 | CHIMERIC | 1 | 0.5 | 0 | 9
|
| 103 | CHLAMYDIA | 2 | 1.0 | 0 | 1
|
| 104 | CHRONIC | 1 | 0.5 | 0 | 2
|
| 105 | CLEAVAGE | 1 | 0.5 | 2 | 5
|
| 106 | CLOSER | 1 | 0.5 | 0 | 0
|
| 107 | COMPLEX | 6 | 3.1 | 6 | 39
|
| 108 | COMPONENTS | 2 | 1.0 | 93 | 208
|
| 109 | CONFERS | 1 | 0.5 | 0 | 0
|
| 110 | CONSERVED | 1 | 0.5 | 2 | 8
|
| 111 | CONTAINING | 1 | 0.5 | 0 | 0
|
| 112 | CONTRIBUTES | 1 | 0.5 | 0 | 1
|
| 113 | CONTROL | 3 | 1.5 | 5 | 82
|
| 114 | CONTROLLING | 1 | 0.5 | 0 | 13
|
| 115 | CONTROLS | 2 | 1.0 | 1 | 7
|
| 116 | CORNEAL | 1 | 0.5 | 0 | 0
|
| 117 | COUNTERACT | 1 | 0.5 | 0 | 0
|
| 118 | CPG | 3 | 1.5 | 1 | 16
|
| 119 | CRITICAL | 2 | 1.0 | 4 | 15
|
| 120 | CRITICALLY | 3 | 1.5 | 0 | 11
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 121 | CRUZI | 1 | 0.5 | 0 | 12
|
| 122 | CULTURE | 1 | 0.5 | 0 | 0
|
| 123 | CUTTING | 2 | 1.0 | 2 | 5
|
| 124 | CWS | 1 | 0.5 | 0 | 1
|
| 125 | CYCLOOXYGENASE | 1 | 0.5 | 0 | 7
|
| 126 | CYTOKINE | 3 | 1.5 | 2 | 20
|
| 127 | CYTOKINES | 5 | 2.6 | 1 | 13
|
| 128 | CYTOPLASMIC | 1 | 0.5 | 1 | 5
|
| 129 | CYTOTOXIC | 2 | 1.0 | 2 | 2
|
| 130 | CYTOTOXICITY | 1 | 0.5 | 0 | 2
|
| 131 | DANGER | 1 | 0.5 | 0 | 4
|
| 132 | DANIO | 1 | 0.5 | 0 | 0
|
| 133 | DC-VIRUS | 1 | 0.5 | 0 | 3
|
| 134 | DEACTIVATION | 1 | 0.5 | 0 | 10
|
| 135 | DEATH | 1 | 0.5 | 0 | 4
|
| 136 | DEFECTIVE | 1 | 0.5 | 21 | 40
|
| 137 | DEFENCE | 1 | 0.5 | 0 | 0
|
| 138 | DEFENSE | 1 | 0.5 | 0 | 0
|
| 139 | DEFICIENCY | 1 | 0.5 | 11 | 89
|
| 140 | DEFINE | 1 | 0.5 | 5 | 29
|
| 141 | DEFINED | 1 | 0.5 | 0 | 10
|
| 142 | DELTA | 1 | 0.5 | 0 | 3
|
| 143 | DENDRITIC | 17 | 8.8 | 55 | 272
|
| 144 | DENDRITIC-CELL | 1 | 0.5 | 2 | 62
|
| 145 | DEPENDENT | 7 | 3.6 | 27 | 83
|
| 146 | DERIVATIVES | 1 | 0.5 | 0 | 0
|
| 147 | DETECT | 1 | 0.5 | 4 | 57
|
| 148 | DETERMINANTS | 1 | 0.5 | 0 | 0
|
| 149 | DETERMINES | 1 | 0.5 | 4 | 11
|
| 150 | DEVELOPMENT | 3 | 1.5 | 3 | 22
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 151 | DIFFERENTIAL | 7 | 3.6 | 15 | 53
|
| 152 | DIFFERENTIALLY | 3 | 1.5 | 7 | 15
|
| 153 | DIFFERENTIATION | 4 | 2.1 | 2 | 33
|
| 154 | DIMERIZED | 1 | 0.5 | 1 | 9
|
| 155 | DIMINISHED | 1 | 0.5 | 0 | 3
|
| 156 | DIPEPTIDE | 1 | 0.5 | 0 | 0
|
| 157 | DIRECT | 1 | 0.5 | 4 | 23
|
| 158 | DIRECTLY | 1 | 0.5 | 2 | 12
|
| 159 | DISEASE | 2 | 1.0 | 0 | 11
|
| 160 | DISEASES | 1 | 0.5 | 1 | 13
|
| 161 | DISORDERS | 1 | 0.5 | 0 | 1
|
| 162 | DISPLAY | 1 | 0.5 | 2 | 5
|
| 163 | DISSECTION | 1 | 0.5 | 1 | 3
|
| 164 | DISTINCT | 2 | 1.0 | 31 | 53
|
| 165 | DISTINCTIVE | 1 | 0.5 | 0 | 9
|
| 166 | DNA | 1 | 0.5 | 0 | 7
|
| 167 | DOMAIN | 4 | 2.1 | 8 | 46
|
| 168 | DOMAIN-CONTAINING | 8 | 4.1 | 61 | 118
|
| 169 | DOT | 1 | 0.5 | 19 | 43
|
| 170 | DOUBLE | 2 | 1.0 | 10 | 23
|
| 171 | DOUBLE-STRANDED | 8 | 4.1 | 20 | 74
|
| 172 | DSRNA | 3 | 1.5 | 1 | 7
|
| 173 | EBOLA | 1 | 0.5 | 3 | 28
|
| 174 | EDGE | 2 | 1.0 | 2 | 5
|
| 175 | EDGED | 1 | 0.5 | 0 | 3
|
| 176 | EFFECTS | 1 | 0.5 | 0 | 1
|
| 177 | ELEGANS | 2 | 1.0 | 5 | 27
|
| 178 | ELEMENT | 2 | 1.0 | 7 | 13
|
| 179 | ELICITS | 1 | 0.5 | 0 | 1
|
| 180 | EMBRYONIC | 1 | 0.5 | 21 | 40
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 181 | EMERGING | 1 | 0.5 | 0 | 2
|
| 182 | EMPLOYING | 1 | 0.5 | 19 | 43
|
| 183 | ENCODED | 1 | 0.5 | 0 | 1
|
| 184 | ENDOGENOUS | 1 | 0.5 | 5 | 25
|
| 185 | ENDOTHELIAL | 1 | 0.5 | 0 | 4
|
| 186 | ENDOTOXIN | 6 | 3.1 | 30 | 111
|
| 187 | ENDOTOXINS | 1 | 0.5 | 0 | 0
|
| 188 | EPITHELIAL | 3 | 1.5 | 0 | 4
|
| 189 | EPSILON | 3 | 1.5 | 75 | 173
|
| 190 | ESSENTIAL | 6 | 3.1 | 109 | 281
|
| 191 | EVASION | 1 | 0.5 | 2 | 5
|
| 192 | EVITHELIAL | 1 | 0.5 | 1 | 2
|
| 193 | EVOLUTION | 1 | 0.5 | 0 | 0
|
| 194 | EXOGENOUS | 1 | 0.5 | 0 | 6
|
| 195 | EXPANDING | 1 | 0.5 | 2 | 8
|
| 196 | EXPERIMENTAL | 2 | 1.0 | 0 | 0
|
| 197 | EXPRESS | 1 | 0.5 | 0 | 0
|
| 198 | EXPRESSED | 1 | 0.5 | 2 | 5
|
| 199 | EXPRESSION | 14 | 7.2 | 44 | 140
|
| 200 | EXTRINSIC | 1 | 0.5 | 0 | 4
|
Page 1 of 4: [ 1 2 3 4 ]